Phencyclidine-induced release of [3H]dopamine from chopped striatal tissue
- PMID: 7121737
- DOI: 10.1016/0028-3908(82)90006-5
Phencyclidine-induced release of [3H]dopamine from chopped striatal tissue
Abstract
Phencyclidine was examined for its ability to release [3H]dopamine ([3H]DA) from prelabelled chopped rat striatal tissue. A dynamic perfusion system was used in order to minimize the effects of drugs on uptake mechanisms. Cocaine and S-(+)-amphetamine were used to distinguish uptake inhibition from a neurotransmitter releasing action. Phencyclidine, starting at 3 microM caused a dose-dependent increase in efflux of [3H]DA from chopped striatal tissue. In this same preparation, cocaine, a known neuronal uptake inhibitor of dopamine, was unable to release [3H]DA except in the largest dose of 100 microM. S-(+)Amphetamine, a known releaser of neuronal dopamine, was found to be about ten times more potent then phencyclidine in causing a dose-dependent release of [3H]DA. The results of the above experiments are discussed in relation to the ability of phencyclidine to decrease the synaptosomal accumulation of [3H]DA. It is concluded that some of the psychoactive effects of phencyclidine may be due to the ability of phencyclidine to elicit a release of dopamine from dopaminergic neurons.
Similar articles
-
Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices.J Pharmacol Exp Ther. 1982 Dec;223(3):669-74. J Pharmacol Exp Ther. 1982. PMID: 6128403
-
Effects of phencyclidine on the release and synthesis of newly formed dopamine.Neuropharmacology. 1983 Jul;22(7):839-42. doi: 10.1016/0028-3908(83)90129-6. Neuropharmacology. 1983. PMID: 6137782
-
Phencyclidine (PCP)-like inhibition of N-methyl-D-aspartate-evoked striatal acetylcholine release, H-TCP binding and synaptosomal dopamine uptake by metaphit, a proposed PCP receptor acylator.Life Sci. 1987 Dec 14;41(24):2645-54. doi: 10.1016/0024-3205(87)90279-7. Life Sci. 1987. PMID: 2826948
-
Neurobiology of phencyclidine.Monogr Neural Sci. 1987;13:82-90. doi: 10.1159/000414571. Monogr Neural Sci. 1987. PMID: 3317014 Review. No abstract available.
-
[Designer drugs--the phencyclidine series].Pharm Unserer Zeit. 1994 Feb;23(1):52-61. doi: 10.1002/pauz.19940230129. Pharm Unserer Zeit. 1994. PMID: 8159775 Review. German. No abstract available.
Cited by
-
Phencyclidine. Physiological actions, interactions with excitatory amino acids and endogenous ligands.Mol Neurobiol. 1987 Fall;1(3):191-211. doi: 10.1007/BF02936608. Mol Neurobiol. 1987. PMID: 2855791 Review.
-
Psychotomimetic sigma-ligands, dexoxadrol and phencyclidine block the same presynaptic potassium channel in rat brain.J Physiol. 1988 Sep;403:341-53. doi: 10.1113/jphysiol.1988.sp017252. J Physiol. 1988. PMID: 3253423 Free PMC article.
-
Phencyclidine-induced disruption of an aversely motivated two-choice successive discrimination in the rat.Psychopharmacology (Berl). 1990;102(2):171-4. doi: 10.1007/BF02245918. Psychopharmacology (Berl). 1990. PMID: 1980371
-
Inhibition of calcium ATPase by phencyclidine in rat brain.Mol Cell Biochem. 1999 Apr;194(1-2):173-7. doi: 10.1023/a:1006911420745. Mol Cell Biochem. 1999. PMID: 10391137
-
Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants.Psychopharmacology (Berl). 1984;82(1-2):89-92. doi: 10.1007/BF00426387. Psychopharmacology (Berl). 1984. PMID: 6141587